From 56ed71489a7e17a4a5fe65b3668069b71963df9a Mon Sep 17 00:00:00 2001 From: OpenWiki Bot Date: Tue, 28 Jul 2026 02:12:54 +0800 Subject: [PATCH] chore: daily update 2026-07-28 --- .last-update.json | 2 +- commitments.md | 7 +++++ quickstart.md | 2 +- sources/feishu-mail.md | 41 ++++++++++++++++++++++++++ sources/git-repo.md | 63 ++++++++++++++++++++++++++------------- sources/hackernews.md | 38 ++++++++++++++++++++++-- sources/web-search.md | 67 +++++++++++++++++++++++++++++++++++++++++- themes.md | 3 +- 8 files changed, 197 insertions(+), 26 deletions(-) create mode 100644 sources/feishu-mail.md diff --git a/.last-update.json b/.last-update.json index 409a6af..48a61e9 100644 --- a/.last-update.json +++ b/.last-update.json @@ -1,5 +1,5 @@ { - "updatedAt": "2026-07-26T18:21:48.752Z", + "updatedAt": "2026-07-27T18:10:46.353Z", "command": "update", "model": "MiniMax-M3" } diff --git a/commitments.md b/commitments.md index d2bb71a..4484fbe 100644 --- a/commitments.md +++ b/commitments.md @@ -11,6 +11,13 @@ Concrete work tasks, follow-ups, approvals, and scheduled items extracted from G - Status: open - Notes: Single credible regulatory-trade source. Pull the NMPA/CDE-direct release before the next vendor sync; check whether any active CellShot-TriArm or ClinoReactor-class deals depend on the new classification scope. +### celvivo-clinoreactor-thewell-bioscience-xeno-free: verify TheWell Bioscience co-marketing signal on next CelVivo check +- Owner: me +- Source: web-search — thewellbio.com 2026-07-21 / 2026-07-23 / 2026-07-25 (Xeno-Free Cell Culture Media, Stem Cell Culture Product Guide, Apical-Out Organoids white paper — all explicitly name "CelVivo ClinoReactor™") +- Due: unscheduled +- Status: open +- Notes: First vendor-anchored CelVivo ClinoReactor signal in any Tavily pull (prior pulls returned only MO:BOT / generic organoid). TheWell Bioscience is a hydrogel-media partner; their workflow pages position ClinoReactor as the scale-up vessel for apical-out organoids + hMSC expansion. Confirm with CelVivo whether this is a sanctioned co-marketing arrangement and whether it maps to any active Chinese pharma / CDMO deal. +